BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7478078)

  • 21. [A case of acute renal failure in neuroleptic malignant syndrome associated with rhabdomyolysis--possible contributing role of hyperreninemia].
    Fujisawa K; Maruyama Y; Nakamura K; Nagase M
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1169-74. PubMed ID: 7815749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
    Erermis S; Bildik T; Tamar M; Gockay A; Karasoy H; Ercan ES
    Clin Toxicol (Phila); 2007; 45(3):277-80. PubMed ID: 17453880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome.
    Haisma HJ; Constantinou E; Chinyanga HM
    Cent Afr J Med; 1990 May; 36(5):141-3. PubMed ID: 2261628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome: a case report].
    Terlikowska M; Marzański M
    Psychiatr Pol; 1995; 29(3):343-8. PubMed ID: 7652087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study of neuroleptic malignant syndrome in demented patients--examination of our case and reported cases].
    Kimura T; Yoshida H
    No To Shinkei; 1994 Sep; 46(9):859-62. PubMed ID: 7999444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state.
    Rock W; Elias M; Lev A; Saliba WR
    Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Successful electroconvulsive therapy in a pregnant woman with neuroleptic malignant syndrome].
    Verwiel JM; Verwey B; Heinis C; Thies JE; Bosch FH
    Ned Tijdschr Geneeskd; 1994 Jan; 138(4):196-9. PubMed ID: 8107921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuroleptic malignant syndrome--case report].
    Rakus A; Kroczak M
    Przegl Lek; 2001; 58(4):367-70. PubMed ID: 11450372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Undiagnosed progressive supranuclear palsy in a patient with neuroleptic malignant syndrome due to use of neuroleptics: the utility of autopsy in deaths due to known drug reactions.
    Kemp WL; Fitzgerald J; White CL
    Am J Forensic Med Pathol; 2007 Mar; 28(1):59-62. PubMed ID: 17325467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cytokine level and production of reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient with hypersensitivity to neuroleptics.
    Kamińska T; Szuster-Ciesielska A; Wysocka A; Marmurowska-Michałowska H; Dubas-Slemp H; Kandefer-Szerszeń M
    Med Sci Monit; 2003 Jul; 9(7):CS71-5. PubMed ID: 12883457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Atypical" neuroleptic malignant syndrome and the spectrum of malignant cerebrotoxic syndromes.
    Choi-Kain LW; Pope HG
    Harv Rev Psychiatry; 2007; 15(4):181-6. PubMed ID: 17687712
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment.
    Ozen ME; Yumru M; Savas HA; Cansel N; Herken H
    World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comatose patient with neuroleptic malignant syndrome brought by ambulance].
    Takinami Y; Kuroda Y
    Masui; 2012 Jan; 61(1):79-81. PubMed ID: 22338865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of neuroleptic malignant syndrome with acute renal failure].
    Shiono A; Hayashi M; Yamanaka H; Yajima H; Koya J
    Hinyokika Kiyo; 1992 Nov; 38(11):1249-52. PubMed ID: 1485575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroleptic malignant syndrome associated with the syndrome of inappropriate secretion of antidiuretic hormone].
    Yamaguchi K; Takamoto K; Yagi K; Tanabe H
    Rinsho Shinkeigaku; 1995 Feb; 35(2):180-3. PubMed ID: 7781236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia].
    Kucia K; Warchala A
    Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthermic reaction to haloperidol with rigidity, associated to central core disease.
    Calore EE; Cavaliere MJ; Perez NM; Russo DH; Wakamatsu A; Razzouk D
    Acta Neurol (Napoli); 1994 Aug; 16(4):157-61. PubMed ID: 7856468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lethal catatonia and its differential diagnosis with the neuroleptic malignant syndrome].
    Andreu Giménez L; Robert Gates J; Jover Díaz F; Pagán Acosta G; Merino Sánchez J
    Rev Neurol; 2002 Feb 16-28; 34(4):399-400. PubMed ID: 12022063
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of intravenous valproate in a patient with neuroleptic malignant syndrome.
    Tadke RR; Suryavanshi P
    J Neuropsychiatry Clin Neurosci; 2006; 18(1):131-2. PubMed ID: 16525085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.